Sputnik V: Agreement on the production of the Russian vaccine in Italy

The Russian Direct Investment Fund (RDIF) has signed an agreement with the Swiss-based pharmaceutical company Adienne to produce the Russian COVID-19 vaccine. Sputnik V in Italy, the Italian-Russian Chamber of Commerce said in a statement.

The announcement, issued yesterday (Monday, March 8), which was a holiday in Russia, added that the move paves the way for the creation of the first production unit of Sputnik V in Europe, while Italian production is scheduled to start in June. the APE-MPE, citing Reuters.

The Italian-Russian Chamber of Commerce says it hopes 10 million doses of Sputnik V could be produced in Italy by the end of the year.

You may also like